Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401

Condition:   Intervention:   Drug: omaveloxolone Sponsor:   Reata Pharmaceuticals, Inc. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Melanoma | Skin Cancer